Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Rani Therapeutics Holdings, Inc. (RANI) vs Vivani Medical, Inc. (VANI)

Rani Therapeutics Holdings, Inc. and Vivani Medical, Inc. are both Biotechnology companies. Rani Therapeutics Holdings, Inc. and Vivani Medical, Inc. are of similar size ($111.0M and $107.3M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against −51.0%. Vivani Medical, Inc. has the higher net margin (0.00% vs −597.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Rani Therapeutics Holdings, Inc. leads on 9 and Vivani Medical, Inc. on 6.

Valuation

Metric RANI VANI Biotechnology median
P/E n/m n/m 7.88
P/S 28.17 31.96 11.47
P/B 2.96 5.69 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 20.72 26.48 10.73
Earnings yield (35.53%) (28.23%) (28.84%)
Free cash flow yield (14.30%) (24.54%) (23.03%)

Profitability

Metric RANI VANI Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (652.78%) 0.00% 0.00%
Net margin (596.97%) 0.00% 0.00%
Free cash flow margin (402.83%) 0.00% 0.00%
Return on equity (155.24%) (220.40%) (57.72%)
Return on assets (77.54%) (74.60%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RANI VANI Biotechnology median
Revenue growth (TTM) 78.73% (51.00%) 5.64%
EPS growth (last fiscal year) 57.14% 0.00% —
Revenue growth, 5-year CAGR — (0.11%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RANI VANI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.31 3.25 4.73
Net debt to EBITDA 1.33 0.60 0.96

Dividend

Metric RANI VANI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric RANI VANI Biotechnology median
Market cap 107.32m 110.95m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack